02/06/2023
Slingshot Biosciences Announces $11 Million in Series A3 Financing
Customer traction is phenomenal, and we are excited to double down on our commercialization and development efforts for cell and gene therapy customers. We are excited to announce the closing of our Series A3 financing.
https://hubs.li/Q01BsspC0
Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics,